- Ticker
- ADXN
- Price
- 5.50
- Stock movement down
- -0.30 (-5.17%)
- Company name
- Addex Therapeutics Ltd
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Markedsverdi
- 5.29M
- Ent verdi
- -846.10K
- Pris/omsetning
- 4.31
- Pris/bok
- 0.66
- Utbytte avkastning
- -
- Utbytte vekst
- -
- Vekst år
- -
- FCF-utbetaling
- -
- Etterfølgende P/E
- -
- Fremtidig P/E
- -
- PEG
- -
- EPS-vekst
- -
- 1 års avkastning
- -61.95%
- 3 års avkastning
- -70.36%
- 5 års avkastning
- -
- 10 års avkastning
- -
Sist oppdatert: 2023-12-06
The following slide deck was published by Addex Therapeutics Ltd in conjunction with their 2023 Q3 earnings call.
29. november 2023
iO Charts is a Seeking Alpha partner
Addex Therapeutics Ltd. (NASDAQ:NASDAQ:ADXN) Q3 2023 Earnings Conference Call November 29, 2023 10:00 AM ETCompany ParticipantsTim Dyer - Chief Executive...
29. november 2023
iO Charts is a Seeking Alpha partner
UTBYTTE
ADXN betaler ikke utbytte
Get the latest news and real-time alerts from Addex Therapeutics Ltd (ADXN) stock at Seeking Alpha.
29. november 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Addex Therapeutics Ltd (ADXN) stock at Seeking Alpha.
8. november 2023
iO Charts is a Seeking Alpha partner
VERDSETTELSE
Verdsettelsesforhold
Loading...
Verdsettelsesforhold-data
| Etterfølgende P/E | - |
| Pris til OCF | - |
| Pris til FCF | - |
| Pris til EBITDA | - |
| EV i forhold til EBITDA | - |
Verdsettelse (Salg/Bokført verdi)
Loading...
Verdsettelse (Salg/Bokført verdi) data
| Pris til omsetning | 4.31 |
| Pris til bok | 0.66 |
| EV i forhold til salg | -0.69 |
Addex Therapeutics Ltd (NASDAQ:NASDAQ:ADXN) Q2 2023 Results Conference Call August 10, 2023 10:00 AM ETCompany ParticipantsTim Dyer - Chief Executive...
11. august 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Addex Therapeutics Ltd (ADXN) stock at Seeking Alpha.
10. august 2023
iO Charts is a Seeking Alpha partner
ØKONOMI
Per aksje
Loading...
Per aksje-data
| Gjeldende aksje antall | 961.24K |
| EPS (TTM) | -54.18 |
| FCF per aksje (TTM) | -41.02 |
Resultatregnskap
Loading...
Resultatregnskap-data
| Inntekter (TTM) | 1.23M |
| Bruttofortjeneste (TTM) | 0.00 |
| Driftsinntekter (TTM) | -21.30M |
| Netto inntekt (TTM) | -21.58M |
| EPS (TTM) | -54.18 |
| EPS (1 år fremover) | - |
Marginer
Loading...
Marginer-data
| Bruttomargin (TTM) | - |
| Driftsmargin (TTM) | -1735.01% |
| Fortjenestemargin (TTM) | -1757.77% |
Balanse
Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Balanse-data
| Kontanter | 10.42M |
| Netto fordringer | 457.04K |
| Samlede omløpsmidler | 11.70M |
| Goodwill | 0.00 |
| Immaterielle eiendeler | 0.00 |
| Eiendom, anlegg og utstyr | 0.00 |
| Sum eiendeler | 12.24M |
| Leverandørgjeld | 2.99M |
| Kortsiktig/nåværende langsiktig gjeld | 447.11K |
| Sum kortsiktig gjeld | 4.13M |
| Sum gjeld | 4.29M |
| Aksjonærenes egenkapital | 7.95M |
| Netto varige driftsmidler | 7.95M |
Kontantstrøm
Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Kontantstrøm-data
| Kontantstrøm fra drift (TTM) | -16.31M |
| Kapitalutgifter (TTM) | 26.23K |
| Fri kontantstrøm (TTM) | -16.34M |
| Utbetalt utbytte (TTM) | 0.00 |
Finansielle inntekter
Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Finansielle inntekter-data
| Egenkapitalavkastning | -271.34% |
| Avkastning på eiendeler | -176.26% |
| Avkastning på investert kapital | -261.93% |
| Kontantavkastning på investert kapital | -198.31% |
Get the latest news and real-time alerts from Addex Therapeutics Ltd (ADXN) stock at Seeking Alpha.
3. august 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Addex Therapeutics Ltd (ADXN) stock at Seeking Alpha.
18. mai 2023
iO Charts is a Seeking Alpha partner
AKSJEINFORMASJON
Aksjediagram
Loading...
Aksjekurs-data
| Åpning | 5.99 |
| Daglig høy | 6.00 |
| Daglig lav | 5.50 |
| Daglig volum | 11K |
| Tidenes høyeste | 483.80 |
| 1 år analytikerestimat | - |
| Beta | 1.77 |
| EPS (TTM) | -54.18 |
| Utbytte per aksje | - |
| Ex-div dato | - |
| Neste dato for resultatpresentasjon | - |
Nedsidepotensial
Loading...
Nedsidepotensial-data
| ADXN | S&P500 | |
| Nåværende prisfall fra toppnotering | -98.86% | -4.80% |
| Høyeste prisfall | -98.91% | -56.47% |
| Dato for høyeste fall | 9 Nov 2023 | 9 Mar 2009 |
| Gj.snittlig fall fra topp | -73.48% | -11.47% |
| Gj.snittlig tid til ny topp | 303 days | 13 days |
| Maks tid til ny topp | 742 days | 1805 days |
Addex Therapeutics Ltd. (NASDAQ:NASDAQ:ADXN) Q1 2023 Earnings Conference Call May 11, 2023 10:00 AM ETCompany ParticipantsTimothy Dyer – Chief Executive...
12. mai 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Addex Therapeutics Ltd (ADXN) stock at Seeking Alpha.
11. mai 2023
iO Charts is a Seeking Alpha partner
SELSKAPSOPPLYSNINGER
Markedsverdi
5.29M
Markedsverdi kategori
Small-cap
Beskrivelse
Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc.; Indivior PLC; and The Charcot"Marie"Tooth Association. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.
Ansatte
26
Investorrelasjoner
-
SEC-innsendelser
Adm. direktør
Timothy Dyer
Land
USA
By
Geneva
Aksjetype
American depositary share
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRESENTASJONER
ArrangementerPresentasjoner
Loading...
Addex Therapeutics Ltd. (NASDAQ:NASDAQ:ADXN) Q4 2022 Results Conference Call March 30, 2023 10:00 AM ETCompany ParticipantsTimothy Dyer - CEORobert Lutjens...
31. mars 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Addex Therapeutics Ltd (ADXN) stock at Seeking Alpha.
30. mars 2023
iO Charts is a Seeking Alpha partner
FORSTÅ VIRKSOMHETEN
Loading...
NYHETER OM SELSKAPET
Seeking AlphaPressemeldinger
Get the latest news and real-time alerts from Addex Therapeutics Ltd (ADXN) stock at Seeking Alpha.
9. februar 2023
Get the latest news and real-time alerts from Addex Therapeutics Ltd (ADXN) stock at Seeking Alpha.
8. desember 2022
Addex Therapeutics Ltd (NASDAQ:NASDAQ:ADXN) Q3 2022 Earnings Conference Call November 11, 2022 11:00 AM ETCompany ParticipantsTim Dyer - Co-Founder, Board...
11. november 2022
Get the latest news and real-time alerts from Addex Therapeutics Ltd (ADXN) stock at Seeking Alpha.
11. november 2022
Get the latest news and real-time alerts from Addex Therapeutics Ltd (ADXN) stock at Seeking Alpha.
3. november 2022
Addex Therapeutics Ltd (NASDAQ:NASDAQ:ADXN) Q2 2022 Earnings Conference Call August 18, 2022 10:00 AM ETCompany ParticipantsTim Dyer - Co-Founder, Board...
18. august 2022
Get the latest news and real-time alerts from Addex Therapeutics Ltd (ADXN) stock at Seeking Alpha.
18. august 2022
Get the latest news and real-time alerts from Addex Therapeutics Ltd (ADXN) stock at Seeking Alpha.
15. august 2022
Get the latest news and real-time alerts from Addex Therapeutics Ltd (ADXN) stock at Seeking Alpha.
22. juli 2022
Get the latest news and real-time alerts from Addex Therapeutics Ltd (ADXN) stock at Seeking Alpha.
17. juni 2022
iO Charts is a Seeking Alpha partnerNeste side